BCM
LLY icon

Brooktree Capital Management’s Eli Lilly LLY Stock Holding History

Brooktree Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$730K Sell
794
-1,264
-61% -$1.28M 0.58% 27
2025
Q4 		$2.21M Sell
2,058
-10
-0.5% -$9.56K 1.47% 17
2025
Q3 		$1.58M Sell
2,068
-178
-8% -$132K 1% 17
2025
Q2 		$1.75M Sell
2,246
-218
-9% -$169K 1.14% 16
2025
Q1 		$2.04M Sell
2,464
-1,721
-41% -$1.43M 1.53% 13
2024
Q4 		$3.23M Sell
4,185
-21
-0.5% -$17.4K 2.4% 11
2024
Q3 		$3.73M Sell
4,206
-418
-9% -$376K 3.03% 11
2024
Q2 		$4.19M Sell
4,624
-1,208
-21% -$966K 3.58% 10
2024
Q1 		$4.54M Sell
5,832
-1,257
-18% -$895K 3.5% 12
2023
Q4 		$4.13M Sell
7,089
-89
-1% -$51.9K 3.34% 13
2023
Q3 		$3.86M Sell
7,178
-496
-6% -$256K 3.22% 14
2023
Q2 		$3.6M Sell
7,674
-579
-7% -$243K 2.74% 15
2023
Q1 		$2.83M Sell
8,253
-661
-7% -$223K 2.21% 17
2022
Q4 		$3.26M Hold
8,914
– – 2.68% 17
2022
Q3 		$2.88M Sell
8,914
-427
-5% -$135K 2.37% 17
2022
Q2 		$3.03M Sell
9,341
-219
-2% -$65.7K 2.28% 16
2022
Q1 		$2.74M Sell
9,560
-2,379
-20% -$612K 1.78% 18
2021
Q4 		$3.3M Sell
11,939
-1,054
-8% -$267K 2.02% 17
2021
Q3 		$3M Sell
12,993
-376
-3% -$92.8K 1.91% 18
2021
Q2 		$3.07M Sell
13,369
-20
-0.1% -$4.02K 1.97% 17
2021
Q1 		$2.5M Sell
13,389
-140
-1% -$27.4K 1.68% 20
2020
Q4 		$2.28M Sell
13,529
-837
-6% -$125K 1.68% 21
2020
Q3 		$2.13M Sell
14,366
-220
-2% -$34K 1.8% 19
2020
Q2 		$2.39M Sell
14,586
-93
-0.6% -$14.3K 2.25% 18
2020
Q1 		$2.04M Hold
14,679
– – 2.36% 17
2019
Q4 		$1.93M Buy
+14,679
New +$1.7M 1.77% 22

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Brooktree Capital Management's LLY Position: Q1 2026 in Review

Brooktree Capital Management reduced its Eli Lilly (LLY) stake by 61% in Q1 2026, selling an estimated $1.28M and leaving 794 shares worth $730K. The position accounts for 0.58% of the portfolio, ranked #27.

Brooktree Capital Management first reported a position in LLY in Q4 2019 and has held it in 26 quarters since. The position peaked at $4.54M in Q1 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Brooktree Capital Management held 794 shares of Eli Lilly worth $730K as of Q1 2026.
  • Brooktree Capital Management sold 1,264 Eli Lilly shares in Q1 2026, an estimated $1.28M.
  • Eli Lilly made up 0.58% of Brooktree Capital Management's portfolio in Q1 2026, its #27 holding.
  • Brooktree Capital Management first reported a position in Eli Lilly in Q4 2019 and has held it in 26 quarters since.
  • Brooktree Capital Management's Eli Lilly position peaked at $4.54M in Q1 2024.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Brooktree Capital Management's 13F filing for Q1 2026, filed 6 May 2026.